ALVR

ALVR

USD

AlloVir Inc. Common Stock

$9.810+0.260 (2.723%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Aucune donnée graphique disponible

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$9.550

Haut

$10.320

Bas

$9.550

Volume

N/A

Fondamentaux de l'Entreprise

Capitalisation Boursière

49.5M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.02M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $7.96Actuel $9.810Haut $24.15

Actualités Connexes

GlobeNewswire

Kalaris and AlloVir Announce Stockholder Approval of Merger

PALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. ("Kalaris"), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of

Voir plus
Kalaris and AlloVir Announce Stockholder Approval of Merger
PR Newswire

SHAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ALVR, IPG, AVAV, WMPN to Act Now

Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by...

Voir plus
SHAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ALVR, IPG, AVAV, WMPN to Act Now
PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPG, ALVR, WMPN, AVAV on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Voir plus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPG, ALVR, WMPN, AVAV on Behalf of Shareholders

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.